BP-897

From WikiMD's Food, Medicine & Wellness Encyclopedia

BP-897 Structure.svg

BP-897 is a synthetic compound that acts as a selective dopamine receptor D3 partial agonist. It has been primarily researched for its potential therapeutic effects in the treatment of drug addiction, particularly cocaine addiction.

Pharmacology[edit | edit source]

BP-897 exhibits high affinity and selectivity for the dopamine receptor D3 subtype, which is predominantly expressed in the limbic system of the brain. This region is associated with the regulation of emotion and reward, making D3 receptors a target for addressing addictive behaviors. By partially activating these receptors, BP-897 is thought to modulate the dopaminergic system and reduce the reinforcing effects of addictive substances.

Research and Development[edit | edit source]

Initial studies on BP-897 have shown promising results in animal models of addiction. Research indicates that BP-897 can reduce self-administration of cocaine in rodents, suggesting its potential as a treatment for cocaine dependence. Further studies are needed to evaluate its efficacy and safety in humans.

Mechanism of Action[edit | edit source]

BP-897's mechanism of action involves partial agonism at the D3 receptor, which means it activates the receptor to a lesser degree than the endogenous ligand, dopamine. This partial activation is believed to help normalize the dopaminergic signaling in the brain, which is often dysregulated in individuals with substance use disorders.

Potential Therapeutic Uses[edit | edit source]

While the primary focus of BP-897 research has been on cocaine addiction, its selective action on D3 receptors suggests it may have broader applications in treating other forms of addiction and possibly neuropsychiatric disorders where the dopaminergic system is implicated.

Side Effects and Safety[edit | edit source]

As BP-897 is still under investigation, comprehensive data on its side effects and long-term safety profile are not yet available. Preliminary studies have not reported significant adverse effects, but further clinical trials are necessary to establish its safety in humans.

See Also[edit | edit source]

References[edit | edit source]

External Links[edit | edit source]

-


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD